Vaxcyte Inc (NASDAQ: PCVX) is 29.57% higher on its value in year-to-date trading and has touched a low of $44.20 and a high of $85.61 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The PCVX stock was last observed hovering at around $83.24 in the last trading session, with the day’s loss setting it -1.87%.
Currently trading at $81.37, the stock is 4.89% and 11.01% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.03 million and changing -2.25% at the moment leaves the stock 27.48% off its SMA200. PCVX registered 70.73% gain for a year compared to 6-month gain of 31.77%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 11.56% loss in the last 1 month and extending the period to 3 months gives it a 30.74%, and is 0.48% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.27% over the week and 3.48% over the month.
Vaxcyte Inc (PCVX) has around 254 employees, a market worth around $8.85B and $0.00M in sales. Distance from 52-week low is 84.10% and -4.95% from its 52-week high. The company has generated returns on investments over the last 12 months (-21.80%).
The EPS is expected to grow by 3.11% this year
The shares outstanding are 108.80M, and float is at 103.40M with Short Float at 9.94%.
Vaxcyte Inc (PCVX) Insider Activity
The most recent transaction is an insider sale by Cowan Elvia, the company’s SVP, FINANCE. SEC filings show that Cowan Elvia sold 5,000 shares of the company’s common stock on Jul 16 ’24 at a price of $85.00 per share for a total of $0.42 million. Following the sale, the insider now owns 12723.0 shares.
Vaxcyte Inc disclosed in a document filed with the SEC on Jul 08 ’24 that Cowan Elvia (SVP, FINANCE) sold a total of 5,000 shares of the company’s common stock. The trade occurred on Jul 08 ’24 and was made at $80.00 per share for $0.4 million. Following the transaction, the insider now directly holds 12723.0 shares of the PCVX stock.
Still, SEC filings show that on Jul 01 ’24, Wassil Jim (CHIEF OPERATING OFFICER) disposed off 3,000 shares at an average price of $76.34 for $0.23 million. The insider now directly holds 210,503 shares of Vaxcyte Inc (PCVX).
